Latest Prostate Cancer Research News

Dan Theodorescu, MD, PhD, Director of Cedars-Sinai Cancer Center in Los Angeles immigrated to Canada from Bucharest, Romania as a young boy.  Both of his parents were “math people,” his father an internationally renowned mathematics professor. Theodorescu was named after…

Ting Martin Ma, MD, PhD, from the University of California, Los Angeles and colleagues conducted a systematic literature review and meta-analysis of data from randomized clinical trials of definitive radiotherapy for patients with localized prostate cancer.  The selected studies enrolled…

As the Principal Investigator of the Northwestern University-based Prostate Cancer SPORE (Specialized Program of Research Excellence) Grant from 2015-2021, Dr. Catalona was required by the National Cancer Institute to report on the outcomes of the award.  Below is summary of…

Thomas (“Tom”) A. McGurk, Jr., a three-year letterman in basketball at DePauw University in Greencastle, Indiana, from 1966-1968 ranks third in school history in rebounds per game, seventh in career rebounds, and fifteenth in points per game.  He earned second-team…

Active surveillance (AS) is the recommended initial management strategy for most patients with low-grade prostate cancer and an option for selected patients with favorable intermediate-risk disease and is adopted by the majority of eligible patients.  Evidence supports the long-term safety…

Urologists at the University of Texas Health and MD Anderson Cancer Center, San Antonio conducted a pilot study involving 29 men aged 30 to 80 years with a new prostate cancer diagnosis scheduled to undergo radical prostatectomy.  They randomly assigned…

 Dr. Ravi B. Parikh and his team, from the University of Pennsylvania Perelman School of Medicine, reported that the overall survival disparity between Black and White men may be due to decreased benefits associated with abiraterone treatment in White men. …

Researchers investigated whether statin use was associated with the outcomes of a randomized PSA- based prostate cancer screening trial. Data was used from a Finnish population-based study of prostate cancer screening that randomized men to PSA screening or routine care….

Decreases in PSA testing followed the 2012 USPSTF grade D recommendation on PSA testing and have been associated with increasing proportions of higher-stage disease and increasing incidence of metastatic disease.  In April 2017, the US Preventive Services Task Force (USPSTF)…